-
Here's Why Phreesia's Average Revenue Per Client Will Accelerate: Analyst
Wednesday, January 8, 2025 - 1:30pm | 303Read More...Growth in Phreesia Inc‘s (NYSE:PHR) average revenue per client is poised to accelerate, according to RBC Capital Markets. The Analyst: Analyst Sean Dodge upgraded the rating for Phreesia from Sector Perform to Outperform. He also raised the price target from $24 to $32. The Thesis:...
-
Teladoc Health Delivers Mixed Results, 'Sobering' Guidance: 6 Analysts Provide Key Takeaways
Wednesday, February 21, 2024 - 1:44pm | 704Read More...Shares of Teladoc Health Inc (NYSE: TDOC) tanked in early trading on Wednesday, after the company misses revenue expectations for the fourth quarter and issued weak first-quarter guidance. The results came amid an exciting earnings season. Here are some key analyst takeaways from the release. RBC...
-
Teladoc Analysts React To Shocking Q1 Losses, Rising BetterHelp Costs
Thursday, April 28, 2022 - 2:25pm | 494Read More...A brutal 12 months for Teladoc Health Inc (NYSE: TDOC) went from bad to much worse on Thursday when the stock dropped another 43% after the company reported much larger-than-expected losses in the first quarter and slashed its 2022 guidance. On Wednesday, Teladoc reported a whopping EPS loss of $41...
-
Is Cerner Still A Growth Company?
Sunday, February 12, 2017 - 12:29pm | 367Read More...Shares of Cerner Corporation (NASDAQ: CERN) were in the red following weak full-year outlook, but that doesn’t deter Jefferies and Cantor Fitzgerald from changing their bullish thesis on the stock. Despite in-line results, Cerner cut its 2017 revenue outlook to $5.1 billion to $5.3 billion...
-
Jefferies Unveils One Healtchare IT Stock To Buy, One To Sell
Friday, October 16, 2015 - 9:40am | 394Read More...Cerner Corporation (NASDAQ: CERN) shares are down 12 percent in the last six months, while shares of athenahealth, Inc (NASDAQ: ATHN) have risen 13 percent in the same period. Jefferies’ Sean Dodge maintained a Buy rating on Cerner, while downgrading athenahealth from Hold to...
-
Jefferies Boosts Targets Across Pharmaceutical Service Stocks
Wednesday, May 27, 2015 - 11:59am | 451Read More...Jefferies commented on Pharmaceutical services stocks Wednesday and expected accelerated R&D spending for 2015 and 2016. Analysts David Windley and Sean Dodge surveyed 60 R&D decision-makers who expected “their outsourced budgets to grow in the high-teens, which would be the...
-
UPDATE: Jefferies Initiates Coverage On Owens & Minor On Expected Steady Growth
Wednesday, July 2, 2014 - 10:09am | 114Read More...In a report published Wednesday, Jefferies analyst Sean Dodge initiated coverage on Owens & Minor (NYSE: OMI) with a Hold rating and $36.00 price target. In the report, Jefferies noted, “OMI is the largest distributor of medical & surgical supplies to U.S. hospitals. The outlook for...
-
UPDATE: Jefferies Initiates Coverage On Premier On Unique Business Model
Wednesday, July 2, 2014 - 10:08am | 110Read More...In a report published Wednesday, Jefferies analyst Sean Dodge initiated coverage on Premier (NASDAQ: PINC) with a Buy rating and $36.00 price target. In the report, Jefferies noted, “We recommend buying PINC, one of the best-positioned informatics vendors, to capitalize on the ongoing shift to...
-
UPDATE: Jefferies Initiates Coverage on Healthcare Services Group on Great Fundamentals, Full Valuation
Friday, September 27, 2013 - 10:49am | 113Read More...In a report published Friday, Jefferies analyst Sean Dodge initiated coverage on Healthcare Services Group (NASDAQ: HCSG) with a Hold rating and $25.00 price target. In the report, Jefferies noted, “Demand for HCSG's services will grow as post-acute facilities search for ways to cope with an...
-
UPDATE: Jeffries Initiates MedAssets at Buy on Attractive Pricing
Tuesday, July 16, 2013 - 8:33am | 124Read More...In a report published on Tuesday, Jefferies analyst Sean Dodge initiated coverage on MedAssets (NASDAQ: MDAS) with a Buy rating and $23 price target on the company. In the report, Jeffries commented, "Attractively Priced Play on Healthcare Reform. Demand for MedAssets capabilities will grow as...
-
Jefferies Still Thinks McKesson is Cheap After Mixed Earnings
Monday, August 2, 2010 - 9:35am | 77Read More...Jefferies analysts Richard Close, Dana Hambly, and Sean Dodge reiterated a Buy rating for McKesson (NYSE: MCK) after mixed earnings numbers. The analysts said, "MCK maneuvered through a challenging quarter and maintained annual guidance despite weak utilization and some Canadian regulatory...
-
Jefferies Initiates Stericycle, Inc With Buy (SRCL)
Friday, July 9, 2010 - 10:40am | 136Read More...Jefferies analysts Richard Close, Sean Dodge, and Dana Hambly initiated coverage of Stericycle, Inc. (NASDAQ: SRCL) with a Buy rating. Stericycle provides regulated waste management services to institutions such as hospitals, pharmaceutical companies, and other generators of regulated waste. The...
-
Jefferies Likes Merger Of Allscripts-Misys Healthcare Solutions (MDRX) And Eclipsys (ECLP)
Thursday, June 10, 2010 - 9:12am | 209Read More...Jefferies & Company analysts Richard Close, Dana Hambly and Sean Dodge said that if the merger of Allscripts-Misys Healthcare Solutions Inc (Nasdaq: MDRX) and Eclipsys Corporation (Nasdaq: ECLP) goes through, the deal will alter the competitive balance in the HCIT segment. The analysts said...
